Navigation Links
Patients Buy Untried Cancer Drug On Web

Nature magazine has reported that cancer patients have been buying an untried drug in the web hoping to find some remedy for their illness//. The drug called DCA, short form for dichlroacetate has been reported to decrease the size of tumors in rats. But it has not been tested in humans so far.

Understandably, terminally sick patients do not want to wait for the research in humans and it has been reported that around two hundred patients worldwide have bought this drug over the net.

Dr Evangelos Michelakis, from University of Alberta in Canada, has been investigating the drug DCA, or dichloroacetate in rats. It is a small molecule which blocks an enzyme in mitochondria that generate energy in cells and also control cell suicide. Tests on rats indicated that DCA prompts the cancer cells to die and tumors shrank by around 75% in three weeks. Related work on DCA also suggests that it can kill human cancer cells in lab but patients have not been tested with this.

Dr Michelakis feels that this sort of use of the drug could weaken attempts to carry out a controlled trial. It is also essential to find out about the contra indications of the drugs. The US FDA is investigating the web purchasing of DCA. According to health experts terminally ill patients are keen to try whatever is available as they feel they have nothing to lose. But Professor John Toy, medical director of Cancer Research UK strongly advised patients not to buy DCA.
JYT
'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: